JP2015536446A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015536446A5 JP2015536446A5 JP2015536969A JP2015536969A JP2015536446A5 JP 2015536446 A5 JP2015536446 A5 JP 2015536446A5 JP 2015536969 A JP2015536969 A JP 2015536969A JP 2015536969 A JP2015536969 A JP 2015536969A JP 2015536446 A5 JP2015536446 A5 JP 2015536446A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- probe
- heteroalkyl
- kit according
- tec family
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000523 sample Substances 0.000 claims 13
- 239000003795 chemical substances by application Substances 0.000 claims 8
- 125000004404 heteroalkyl group Chemical group 0.000 claims 8
- 125000000547 substituted alkyl group Chemical group 0.000 claims 8
- 102000042834 TEC family Human genes 0.000 claims 6
- 108091082333 TEC family Proteins 0.000 claims 6
- 238000001514 detection method Methods 0.000 claims 5
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 4
- 125000003107 substituted aryl group Chemical group 0.000 claims 4
- 108091000080 Phosphotransferase Proteins 0.000 claims 3
- 239000011324 bead Substances 0.000 claims 3
- 229940043355 kinase inhibitor Drugs 0.000 claims 3
- 102000020233 phosphotransferase Human genes 0.000 claims 3
- 239000003757 phosphotransferase inhibitor Substances 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- 239000003596 drug target Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 108010090804 Streptavidin Proteins 0.000 claims 1
- 230000002427 irreversible effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261712675P | 2012-10-11 | 2012-10-11 | |
| US61/712,675 | 2012-10-11 | ||
| PCT/US2013/064688 WO2014059368A1 (en) | 2012-10-11 | 2013-10-11 | Companion diagnostics for tec family kinase inhibitor therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015536446A JP2015536446A (ja) | 2015-12-21 |
| JP2015536446A5 true JP2015536446A5 (enExample) | 2016-11-24 |
Family
ID=49510539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015536969A Pending JP2015536446A (ja) | 2012-10-11 | 2013-10-11 | Ｔｅｃファミリーキナーゼ阻害剤療法のためのコンパニオン診断 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150260723A1 (enExample) |
| EP (1) | EP2906556A1 (enExample) |
| JP (1) | JP2015536446A (enExample) |
| KR (1) | KR20150065871A (enExample) |
| CN (1) | CN104755474A (enExample) |
| AU (1) | AU2013328961A1 (enExample) |
| BR (1) | BR112015008042A2 (enExample) |
| CA (1) | CA2887697A1 (enExample) |
| HK (1) | HK1213892A1 (enExample) |
| MX (1) | MX2015004576A (enExample) |
| WO (1) | WO2014059368A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016010961A1 (en) * | 2014-07-15 | 2016-01-21 | Abbvie Inc. | Enzyme occupancy assay |
| TW201618783A (zh) | 2014-08-07 | 2016-06-01 | 艾森塔製藥公司 | 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法 |
| AU2015360547A1 (en) | 2014-12-11 | 2017-06-01 | Merck Patent Gmbh | Assays for BTK inhibitors |
| WO2016100593A1 (en) * | 2014-12-17 | 2016-06-23 | Pharmacyclics Llc | Methods and assays for quantification and normalization of kinase and ligand binding |
| GB201502393D0 (en) * | 2015-02-13 | 2015-04-01 | Univ Leicester | Senescence |
| WO2017141881A1 (ja) * | 2016-02-15 | 2017-08-24 | ノーベルファーマ株式会社 | 遺伝性疾患に関わるタンパク質の測定方法及び測定キット |
| CA3030429A1 (en) | 2016-07-14 | 2018-01-18 | Mingsight Pharmaceuticals, Inc. | Treatment of cancer |
| CN106405086A (zh) * | 2016-09-21 | 2017-02-15 | 四川大学华西医院 | 一种肺癌筛查试剂盒 |
| WO2018134786A1 (en) * | 2017-01-19 | 2018-07-26 | Acerta Pharma B.V. | Compositions and methods for the assessment of drug target occupancy for bruton's tyrosine kinase |
| EP3514541A1 (de) * | 2018-01-17 | 2019-07-24 | Siemens Healthcare Diagnostics Products GmbH | Verfahren zur quantitativen bestimmung eines therapeutischen tnf-alpha inhibitors |
| MX2023014435A (es) | 2021-06-04 | 2024-03-08 | Janssen Pharmaceutica Nv | Inhibidores de la tirosina quinasa de bruton y métodos de su uso. |
| CN114200145A (zh) * | 2022-02-18 | 2022-03-18 | 上海益诺思生物技术股份有限公司 | 酪氨酸激酶浓度的检测方法及试剂盒 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7989465B2 (en) * | 2007-10-19 | 2011-08-02 | Avila Therapeutics, Inc. | 4,6-disubstituted pyrimidines useful as kinase inhibitors |
| EP2361248B1 (en) * | 2008-06-27 | 2018-09-19 | Celgene CAR LLC | Heteroaryl compounds and uses thereof |
-
2013
- 2013-10-11 JP JP2015536969A patent/JP2015536446A/ja active Pending
- 2013-10-11 CA CA2887697A patent/CA2887697A1/en not_active Abandoned
- 2013-10-11 CN CN201380052463.6A patent/CN104755474A/zh active Pending
- 2013-10-11 AU AU2013328961A patent/AU2013328961A1/en not_active Abandoned
- 2013-10-11 EP EP13783762.1A patent/EP2906556A1/en not_active Withdrawn
- 2013-10-11 BR BR112015008042A patent/BR112015008042A2/pt not_active IP Right Cessation
- 2013-10-11 HK HK16101892.9A patent/HK1213892A1/zh unknown
- 2013-10-11 US US14/434,015 patent/US20150260723A1/en not_active Abandoned
- 2013-10-11 WO PCT/US2013/064688 patent/WO2014059368A1/en not_active Ceased
- 2013-10-11 MX MX2015004576A patent/MX2015004576A/es unknown
- 2013-10-11 KR KR1020157011983A patent/KR20150065871A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015536446A5 (enExample) | ||
| Cha et al. | Performance evaluation of the OraQuick hepatitis C virus rapid antibody test | |
| JP2013535009A5 (enExample) | ||
| JP2015532646A5 (enExample) | ||
| JP2015529199A5 (enExample) | ||
| EA201792497A1 (ru) | Антитела к gitr для диагностики злокачественной опухоли | |
| JP2014508298A5 (enExample) | ||
| BR112015013555A2 (pt) | sistema médico para detectar eventos arrítmicos | |
| HK1213892A1 (zh) | Tec家族激酶抑制剂疗法的伴随诊断 | |
| EP4354146A3 (en) | Immunoassay for the detection of cleaved high molecular weight kininogen | |
| JP2016532695A5 (enExample) | ||
| NO20074065L (no) | Farmakogenomiske markorer for prognose av faste tumorer | |
| Cameron et al. | Viral genome replication | |
| DE602004016906D1 (de) | Reagenz zum Nachweis von anti-Phospholipid Antikörper | |
| DK1768704T3 (da) | Billeddannelse af infektion med forbindelser der binder til thymidinkinase | |
| JP2012522222A5 (enExample) | ||
| JP2006030037A5 (enExample) | ||
| JP2016527206A5 (enExample) | ||
| Kreitzer | HUMPHREY GILLET: Signatory of A Testimony to Truth (1659) | |
| TH1901002538A (th) | วิธีการสำหรับการประเมินความเสี่ยงของปฏิกิริยาภูมิไวเกินต่อยาที่ถูกเหนี่ยวนำโดยซัลฟาเมทอกซาโซล และ/หรือไตรเมโทพริม | |
| TH179003A (enExample) | ||
| TH176451A (th) | Egfr/c- met แอนติบอดีแบบจำเพาะต่อสองเป้าหมาย | |
| UA111256U (uk) | Спосіб діагностики розвитку остеопорозу | |
| UA111292U (uk) | Спосіб діагностики розвитку остеопорозу | |
| UA113286U (uk) | Спосіб діагностики розвитку остеопорозу |